Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly.

The Journal of clinical endocrinology and metabolism - 1 Nov 2005

Bhayana Shelly, Booth Gillian L, Asa Sylvia L, Kovacs Kalman, Ezzat Shereen

Abstract excerpt

CONTEXT: Persistently elevated GH and IGF-I levels are associated with increased mortality. Their response to somatostatin analogs (SSA) is variable. OBJECTIVE: The objective of this study was to examine the significance of somatotroph adenoma type on response to SSA. DESIGN: This study was a retrospective examination of postoperatively treated acromegalic patients with the SSA octreotide. SETTING: The study was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acromegaly
Share to Adenoma
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Human Growth Hormone

Share to Insulin-Like Growth Factor I

Share to Multivariate Analysis

Share to Phenotype

Share to Pituitary Neoplasms

Source

Identifiers

PMID: 16118335
DOI: 10.1210/jc.2005-0998

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly.PMID 16118335Read ↗

Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas.Semantic proximity Read ↗

Clinical characteristics associated with somatic GNAS mutations in acromegaly: a systematic review and institutional experience.Semantic proximity Read ↗

Growth hormone-producing pituitary adenomas in childhood and young adulthood: clinical features and outcomes.Semantic proximity Read ↗

Treatment of acromegaly in the era of personalized and predictive medicine.Semantic proximity Read ↗

Acromegaly: unravelling a complex disease.Semantic proximity Read ↗

Molecular Characterization of Growth Hormone-producing Tumors in the GC Rat Model of Acromegaly.Semantic proximity Read ↗

Human Somatostatin Receptor Subtypes in Acromegaly: Distinct Patterns of Messenger Ribonucleic Acid Expression and Hormone Suppression Identify Different Tumoral PhenotypesSemantic proximity Read ↗

Co-secretion of growth hormone and prolactin defines a high-risk acromegaly phenotype.Semantic proximity Read ↗

Co-secretion of growth hormone and prolactin defines a high-risk acromegaly phenotypeSemantic proximity Read ↗

Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3Semantic proximity Read ↗

Efficacy and Safety of Pasireotide Treatment in Acromegaly: A Systematic Review and Single Arm Meta-AnalysisSemantic proximity Read ↗

Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogs: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.